Opening Recap
Market Pulse: Chip stocks rallied as Intel’s Q3 beat ignited a tech lift, while broader equities shrugged off yesterday’s jitters.
Key Movers: Intel surged on an earnings surprise (Slashdot.org), Bayer hit a milestone with FDA approval for its hot-flash therapy (Financial Post), and Scope Ratings rattled traders by downgrading the US credit outlook (Biztoc.com).
Macro & Politics: The US credit warning from Scope underscores that governance issues are creeping into investment-grade assets, reminding everyone that policy gridlock remains a market variable.
What’s Next: Keep an eye on Treasury yields for signs of stress and any headlines on budget brinksmanship as lawmakers return from recess.
Market Commentary
Everyone’s overlooking that the thrill in chips and FDA wins masks an under-the-radar risk in Treasuries. Scope Ratings hammered US credit (Biztoc.com) and that shout-out for political dysfunction should be your wake-up call: one more standoff in Washington, and bond yields could spook even the most bullish tech bulls.
Linking a pharma regulatory breakthrough with a crypto green light reveals a split picture. Bayer’s FDA nod for its hot-flash therapy (Financial Post) sits alongside CZ’s pardon fueling Binance.US expansion (Biztoc.com). This regulatory contrast is an edge for traders who read between the lines.
If you’re loading up on calls after Intel’s pop (Slashdot.org) or chasing crypto rallies, make sure you’re dialed into fiscal headlines. Set a stop-loss on any dip—this bull run isn’t bulletproof against a political meltdown.
📈 Breaking Financial News
Bitcoin Volatility Starts To Cool: Market Prepares For Potential Short Squeeze Rally
Bitcoin is struggling to establish a clear bullish structure in the short term, as selling pressure continues to dominate since the October 10 market crash. The asset remains caught in a volatile range, with traders unsure whether the next major move will mar…
Intel Stock Pops on Estimate-Beating Q3. Options Data Tells Us INTC Could Be Headed Here Next. – Barchart.com
Intel Stock Pops on Estimate-Beating Q3. Options Data Tells Us INTC Could Be Headed Here Next.Barchart.com 3 takeaways from Intel earnings: Cash flow, foundry progress and hardware surpriseCNBC Intel stock jumps as Q3 earnings beat expectations, AI drives chi…
Bayer Wins FDA Approval for Menopause Drug Treating Hot Flashes
Bayer AG won support from US regulators for a menopause drug that’s expected to hit the market in November under the name of Lynkuet.
Inverse Head-and-Shoulders Breakout Puts XRP on Track for $2.80 Test
Failure to hold $2.50 on a closing basis would neutralize the bullish structure, potentially inviting rotation back toward $2.40–$2.42 support.
Jesse Livermore & The Magnet of Dancing Stock Prices
Jesse Livermore on picking tops and bottoms.
The post Jesse Livermore & The Magnet of Dancing Stock Prices appeared first on A Wealth of Common Sense.
…
One specific coin aligns perfectly with Trump's regulatory reforms and vision for America's financial dominance in the digital age.
Get the name of the ideal crypto for Trump's presidency for just $3 before his policies drive prices higher.
🔍 Market Analysis & Insights
30 Million Ounces of Gold Just Moved to the U.S.
And It's Not a Coincidence… A historic gold transfer is underway – and according to 20-year gold analyst Garrett Goggin, it's a clear signal the global monetary system is about to change. Central Banks are already buying at record pace. But Goggin says four tiny miners are positioned for the biggest upside – with 100X potential as this “Golden Anomaly” unfolds. Click here to get all four picks before the window closes.
💰 Investment Opportunities
Crude Pauses Near Two-Week High
Oil prices steadied near recent highs as traders weighed new US sanctions on Russia against a growing supply glut.
White House Insider Buck Sexton: “Trump's Next Move Will Shock the World”
dramatically increase U.S. power… and trigger a massive American market boom the likes of which we haven't seen in 75 years. Get the details here now.